Seth L. Masters

Active 2005–2025

90
Papers
27,881
Citations
68
h-index
88
i10-index

Citations

Citations per year for Seth L. Masters1964: 1 citations1988: 1 citations1991: 2 citations1996: 1 citations2000: 2 citations2003: 1 citations2006: 6 citations2007: 20 citations2008: 66 citations2009: 87 citations2010: 108 citations2011: 152 citations2012: 153 citations2013: 195 citations2014: 223 citations2015: 333 citations2016: 428 citations2017: 526 citations2018: 584 citations2019: 1,436 citations2020: 1,756 citations2021: 1,847 citations2022: 1,670 citations2023: 1,347 citations2024: 1,893 citations2025: 1,062 citations2026: 16 citations1965–1987: no citations, so these years are not shown1989–1990: no citations, so these years are not shown1992–1995: no citations, so these years are not shown1997–1999: no citations, so these years are not shown2001–2002: no citations, so these years are not shown2004–2005: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,955 citing papers, 22.3% of this breakdownChina: 3,683 citing papers, 20.8% of this breakdownGermany: 1,076 citing papers, 6.1% of this breakdownUnited Kingdom: 935 citing papers, 5.3% of this breakdownAustralia: 694 citing papers, 3.9% of this breakdownFrance: 576 citing papers, 3.3% of this breakdownItaly: 573 citing papers, 3.2% of this breakdownCanada: 487 citing papers, 2.7% of this breakdownJapan: 406 citing papers, 2.3% of this breakdownSpain: 396 citing papers, 2.2% of this breakdownNetherlands: 396 citing papers, 2.2% of this breakdownSwitzerland: 347 citing papers, 2% of this breakdown
0%22.3%Other 23.7%

Fields

  • Biochemistry, Genetics and Molecular Biology43%
  • Medicine28.4%
  • Immunology and Microbiology22.2%
  • Neuroscience3.3%
  • Nursing0.7%
  • Agricultural and Biological Sciences0.7%
  • Other1.7%

Topics

  • Inflammasome and immune disorders11.6%
  • interferon and immune responses4.2%
  • Immune cells in cancer3.7%
  • Immune Response and Inflammation2.8%
  • Immune Cell Function and Interaction2.7%
  • IL-33, ST2, and ILC Pathways2%
  • Other73%

Coauthors

All papers

Open in search
  1. Succinate is an inflammatory signal that induces IL-1β through HIF-1α

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ramnik J. Xavier, Luke O'neill - Nature 2013 cited by 4,111

  2. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 2,784

  3. TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2020 cited by 1,038

  4. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice

    Authors: , , , , , , , , , , , , , , - Journal of Hepatology 2017 cited by 1,070

  5. TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells

    Authors: , , , , , , , , , , , , , , , - Cell Reports 2020 cited by 463

  6. Constitutive immune mechanisms: mediators of host defence and immune regulation

    Authors: , , , - Nature reviews. Immunology 2020 cited by 351

  7. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 478

  8. Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage Metabolism

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2018 cited by 447

  9. RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2015 cited by 641

  10. Homeostasis-altering molecular processes as mechanisms of inflammasome activation

    Authors: , - Nature reviews. Immunology 2017 cited by 450

  11. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathrine Hall, Hongying Wang, Jae Jin Chae, Natalia I. Dmitrieva, Mark McKenzie, Amanda Light, Beverly Barham, Anne Jones, Tina Romeo, Qing Zhou, Ivona Aksentijevich, James C. Mullikin, Andrew J. Gross, Anthony K. Shum, Edwin D. Hawkins, Seth L. Masters, Michael J. Lenardo, Manfred Boehm, Sergio D. Rosenzweig, Manolis Pasparakis, Anne K. Voss, Massimo Gadina, Daniel L. Kastner, John Silke - Nature 2019 cited by 333

  12. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2010 cited by 1,315

  13. Organellar homeostasis and innate immune sensing

    Authors: , , , , , , , , , , - Nature reviews. Immunology 2022 cited by 155

  14. ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2022 cited by 167

  15. NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5

    Authors: , , , , , , , , , , , , , , - European Journal of Immunology 2015 cited by 356

  16. Germline NLRP1 Mutations Cause Skin Inflammatory and Cancer Susceptibility Syndromes via Inflammasome Activation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , M. Denguezli, Ali Saâd, Sebastian Hiller, Bruno Reversade - Cell 2016 cited by 438

  17. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue–resident regulatory T cells

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2015 cited by 544

  18. Adipose Tissue Macrophages Promote Myelopoiesis and Monocytosis in Obesity

    Authors: , , , , , , , , , , , , , , , , , - Cell Metabolism 2014 cited by 497

  19. RIPK1 Regulates RIPK3-MLKL-Driven Systemic Inflammation and Emergency Hematopoiesis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2014 cited by 598

  20. Interleukin-1 receptor–associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling

    Authors: , , , , , - Journal of Biological Chemistry 2018 cited by 146

  21. Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome

    Authors: , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2017 cited by 359

  22. The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β Activation

    Authors: , , , , , , , , , , , , , , , , , , , - Cell Reports 2018 cited by 237

  23. Deficiency in coatomer complex I causes aberrant activation of STING signalling

    Authors: , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 96

  24. Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain binding

    Authors: , , , , , , , , , , , , , , , - Journal of Biological Chemistry 2018 cited by 250